Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes

Clinical trial NCT04496479 · RECRUITING

Trial details

NCT number: NCT04496479
Sponsor: LyGenesis, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

End Stage Liver Disease

Start date: 2022-03-11
Primary completion: 2027-08-20
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.